The global Immunocytokines Market is on a high-growth trajectory, expanding from USD 3.29 billion in 2025 to USD 7.76 billion by 2035 at a CAGR of 8.97%. At the heart of this market is one of oncology's most intellectually elegant ideas: what if you could combine the tumor-targeting precision of a monoclonal antibody with the potent immune-activating power of a cytokine, delivering each exactly...